Home/Filings/4/0001562180-24-002289
4//SEC Filing

Cerwinka Franz 4

Accession 0001562180-24-002289

CIK 0001524472other

Filed

Mar 4, 7:00 PM ET

Accepted

Mar 5, 5:01 PM ET

Size

19.8 KB

Accession

0001562180-24-002289

Insider Transaction Report

Form 4
Period: 2024-03-01
Cerwinka Franz
SVP and President, Emerging Ma
Transactions
  • Award

    Common Stock

    2024-03-01$127.94/sh+1,203$153,91212,953 total
  • Award

    Common Stock

    2024-03-01$127.94/sh+1,956$250,25114,909 total
  • Tax Payment

    Common Stock

    2024-03-01$127.94/sh1,509$193,06113,400 total
  • Tax Payment

    Common Stock

    2024-03-01$127.94/sh730$93,39612,670 total
  • Award

    Common Stock

    2024-03-01$127.94/sh+1,563$199,97014,233 total
  • Sale

    Common Stock

    2024-03-01$127.44/sh1,341$170,89712,892 total
  • Award

    Stock Options (Right to buy)

    2024-03-01$127.94/sh+5,288$676,5475,288 total
    Exercise: $127.94Exp: 2034-03-01Common Stock (5,288 underlying)
Footnotes (7)
  • [F1]Reflects the acquisition of 1,203 shares of common stock upon vesting of performance-based restricted stock units granted on March 1, 2021 under the Xylem Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Total Shareholder Return.
  • [F2]Reflects the acquisition of 1,956 shares of common stock upon vesting of performance-based stock units granted on March 1, 2021 under the Xylem Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to ROIC.
  • [F3]Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of performance-based stock units granted on March 1, 2021 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February, 24, 2016).
  • [F4]Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 1, 2021 (193), March 1, 2022 (246), and March 1, 2023 (291) under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016).
  • [F5]Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one third increments on March 1, 2025, March 1, 2026 and March 1, 2027.
  • [F6]This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). These Shares were executed at a price of $127.44. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.
  • [F7]Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 1, 2025, March 1, 2026 and March 1, 2027.

Issuer

Xylem Inc.

CIK 0001524472

Entity typeother

Related Parties

1
  • filerCIK 0001813828

Filing Metadata

Form type
4
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 5:01 PM ET
Size
19.8 KB